HEIGHTS CAPITAL MANAGEMENT, INC
Position in CADL — Candel Therapeutics, Inc.
CIK 1081698
SAN FRANCISCO, CA
Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,797,500
+$3,537,100 QoQ
Shares Held
775,000
+2483.3% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HEIGHTS CAPITAL MANAGEMENT, INC holds $4,440,882 across 2 Biotechnology names. CADL ranks #1 (85.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CADL |
Candel Therapeutics, Inc.
This page
|
775,000 | $3,797,500 | |
| 2 | PMN |
ProMIS Neurosciences Inc.
|
50,660 | $643,382 |
All Filings in CADL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,797,500 | 775,000 | Shares | Other | 2026-05-15 | |
| 2024-12-31 | $260,400 | 30,000 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||